MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

MDT

99.8

-0.46%↓

A

147.83

+0.18%↑

VEEV

238.66

+0.24%↑

HQY

97.62

+2.79%↑

PHR.US

17.5

+1.74%↑

Search

Treace Medical Concepts Inc

Chiusa

2.85 -1.38

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

2.82

Massimo

2.93

Metriche Chiave

By Trading Economics

Entrata

1.1M

-16M

Vendite

2.8M

50M

Margine di Profitto

-32.437

Dipendenti

477

EBITDA

1.3M

-12M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+66.78% upside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-248M

168M

Apertura precedente

4.23

Chiusura precedente

2.85

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

Treace Medical Concepts Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 gen 2026, 23:11 UTC

Utili

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 gen 2026, 22:55 UTC

I principali Market Mover

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 gen 2026, 21:39 UTC

I principali Market Mover

Raytheon Down Following Trump Post Criticizing Company

7 gen 2026, 20:13 UTC

I principali Market Mover

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 gen 2026, 20:03 UTC

I principali Market Mover

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 gen 2026, 23:46 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

7 gen 2026, 23:46 UTC

Discorsi di Mercato

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 gen 2026, 23:42 UTC

Acquisizioni, Fusioni, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 gen 2026, 23:34 UTC

Discorsi di Mercato

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 gen 2026, 23:29 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 gen 2026, 22:48 UTC

Discorsi di Mercato

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 gen 2026, 22:46 UTC

Utili

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 gen 2026, 22:45 UTC

Utili

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 gen 2026, 22:43 UTC

Acquisizioni, Fusioni, Takeovers

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 gen 2026, 22:42 UTC

Utili

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 gen 2026, 22:41 UTC

Utili

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 gen 2026, 22:41 UTC

Utili

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 gen 2026, 22:40 UTC

I principali Market Mover

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 gen 2026, 22:31 UTC

Discorsi di Mercato

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 gen 2026, 22:22 UTC

Discorsi di Mercato

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 gen 2026, 22:01 UTC

Discorsi di Mercato

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

7 gen 2026, 21:46 UTC

Discorsi di Mercato

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 gen 2026, 21:22 UTC

Acquisizioni, Fusioni, Takeovers

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 gen 2026, 21:18 UTC

Acquisizioni, Fusioni, Takeovers

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 gen 2026, 21:05 UTC

Acquisizioni, Fusioni, Takeovers

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 gen 2026, 20:29 UTC

Acquisizioni, Fusioni, Takeovers

AbbVie Near Deal for Revolution Medicines -- Update

7 gen 2026, 20:27 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 gen 2026, 19:58 UTC

Discorsi di Mercato

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 gen 2026, 19:48 UTC

I principali Market Mover

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Confronto tra pari

Modifica del prezzo

Treace Medical Concepts Inc Previsione

Obiettivo di Prezzo

By TipRanks

66.78% in crescita

Previsioni per 12 mesi

Media 4.87 USD  66.78%

Alto 7.5 USD

Basso 3 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Treace Medical Concepts Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

6 ratings

1

Acquista

4

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

7.16 / 7.65Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bullish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
help-icon Live chat